BACKGROUND: Seasonal outbreaks of winter respiratory viruses are responsible for increases in morbidity and mortality in the community. Previous studies have used hospitalizations, intensive care unit and emergency department (ED) visits as indicators of seasonal influenza incidence. OBJECTIVES: To evaluate whether ED visits can be used as a proxy to detect respiratory viral disease outbreaks, as measured by laboratory confirmation. METHODS: An Emergency Department Syndromic Surveillance system was used to collect ED chief complaints in Eastern Ontario from 2006 to 2010. Comparable laboratory-confirmed cases of respiratory viral infections were collected from the Public Health Ontario Laboratory in Kingston, Ontario. Correlations between ED visits and laboratory-confirmed cases were calculated. RESULTS: Laboratory-confirmed cases of selected respiratory viruses were significantly correlated with ED visits for respiratory and fever/influenza-like illness. In particular, respiratory syncytial virus (Spearman's rho = 0.593), rhinovirus (Spearman's rho = 0.280), influenza A (Spearman's rho = 0.528), influenza B (Spearman's rho = 0.426) and pH1N1 (Spearman's rho = 0.470) increased laboratory test levels were correlated with increased volume of ED visits across a number of age demographics. For the entire study population and all studied viruses, the Spearman's rho was 0.702, suggesting a strong correlation with ED visits. Laboratory-confirmed cases lagged in reporting by between one and two weeks for influenza A and pH1N1 compared with ED visit volume. CONCLUSION: These findings support the use of an Emergency Department Syndromic Surveillance system to track the incidence of respiratory viral disease in the community. These methods are efficient and can be performed using automated electronic data entry versus the inherent delays in the primary care sentinel surveillance system, and can aid the timely implementation of preventive and preparatory health interventions.
BACKGROUND: Seasonal outbreaks of winter respiratory viruses are responsible for increases in morbidity and mortality in the community. Previous studies have used hospitalizations, intensive care unit and emergency department (ED) visits as indicators of seasonal influenza incidence. OBJECTIVES: To evaluate whether ED visits can be used as a proxy to detect respiratory viral disease outbreaks, as measured by laboratory confirmation. METHODS: An Emergency Department Syndromic Surveillance system was used to collect ED chief complaints in Eastern Ontario from 2006 to 2010. Comparable laboratory-confirmed cases of respiratory viral infections were collected from the Public Health Ontario Laboratory in Kingston, Ontario. Correlations between ED visits and laboratory-confirmed cases were calculated. RESULTS: Laboratory-confirmed cases of selected respiratory viruses were significantly correlated with ED visits for respiratory and fever/influenza-like illness. In particular, respiratory syncytial virus (Spearman's rho = 0.593), rhinovirus (Spearman's rho = 0.280), influenza A (Spearman's rho = 0.528), influenza B (Spearman's rho = 0.426) and pH1N1 (Spearman's rho = 0.470) increased laboratory test levels were correlated with increased volume of ED visits across a number of age demographics. For the entire study population and all studied viruses, the Spearman's rho was 0.702, suggesting a strong correlation with ED visits. Laboratory-confirmed cases lagged in reporting by between one and two weeks for influenza A and pH1N1 compared with ED visit volume. CONCLUSION: These findings support the use of an Emergency Department Syndromic Surveillance system to track the incidence of respiratory viral disease in the community. These methods are efficient and can be performed using automated electronic data entry versus the inherent delays in the primary care sentinel surveillance system, and can aid the timely implementation of preventive and preparatory health interventions.
Entities:
Keywords:
Emergency department surveillance; Respiratory; Syndromic surveillance; Viral disease
Authors: John P Mullooly; Carolyn B Bridges; William W Thompson; Jufu Chen; Eric Weintraub; Lisa A Jackson; Steve Black; David K Shay Journal: Vaccine Date: 2006-09-25 Impact factor: 3.641
Authors: Rahim Moineddin; Jason X Nie; Gabrielle Domb; Alan M Leong; Ross E G Upshur Journal: BMC Health Serv Res Date: 2008-07-28 Impact factor: 2.655
Authors: Florence T Bourgeois; Karen L Olson; John S Brownstein; Alexander J McAdam; Kenneth D Mandl Journal: Ann Emerg Med Date: 2006-01-18 Impact factor: 5.721
Authors: Tiffany M Wolf; Randall S Singer; Elizabeth V Lonsdorf; Richard Maclehose; Thomas R Gillespie; Iddi Lipende; Jane Raphael; Karen Terio; Carson Murray; Anne Pusey; Beatrice H Hahn; Shadrack Kamenya; Deus Mjungu; Dominic A Travis Journal: Ecohealth Date: 2019-03-05 Impact factor: 3.184
Authors: Ralph J Coates; Alejandro Pérez; Atar Baer; Hong Zhou; Roseanne English; Michael Coletta; Achintya Dey Journal: Disaster Med Public Health Prep Date: 2016-02-17 Impact factor: 1.385
Authors: Sue Smith; Roger Morbey; Richard G Pebody; Thomas C Hughes; Simon de Lusignan; F Alex Yeates; Helen Thomas; Sarah J O'Brien; Gillian E Smith; Alex J Elliot Journal: Emerg Infect Dis Date: 2017-11 Impact factor: 6.883
Authors: Rosanne Barnes; Christopher C Blyth; Nicholas de Klerk; Wei Hao Lee; Meredith L Borland; Peter Richmond; Faye J Lim; Parveen Fathima; Hannah C Moore Journal: BMJ Open Date: 2019-02-24 Impact factor: 2.692
Authors: Jaffar A Al-Tawfiq; Alimuddin Zumla; Philippe Gautret; Gregory C Gray; David S Hui; Abdullah A Al-Rabeeah; Ziad A Memish Journal: Lancet Infect Dis Date: 2014-09-01 Impact factor: 25.071
Authors: Nicholas Papadomanolakis-Pakis; Allison Maier; Adam van Dijk; Nancy VanStone; Kieran Michael Moore Journal: BMC Public Health Date: 2021-06-26 Impact factor: 3.295